Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$62.2 - $84.4 $26.4 Million - $35.9 Million
-425,160 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$73.71 - $87.86 $216 Million - $258 Million
-2,936,632 Reduced 87.35%
425,160 $35.8 Million
Q3 2021

Nov 15, 2021

SELL
$77.92 - $102.4 $94.1 Million - $124 Million
-1,207,013 Reduced 26.42%
3,361,792 $303 Million
Q2 2021

Aug 16, 2021

SELL
$92.19 - $115.71 $259 Million - $325 Million
-2,805,068 Reduced 38.04%
4,568,805 $436 Million
Q1 2021

May 14, 2021

BUY
$106.9 - $167.73 $12 Million - $18.8 Million
111,972 Added 1.54%
7,373,873 $840 Million
Q4 2020

Feb 12, 2021

BUY
$84.4 - $177.39 $40.3 Million - $84.8 Million
477,833 Added 7.04%
7,261,901 $1.01 Billion
Q3 2020

Nov 13, 2020

BUY
$72.98 - $90.0 $328,628 - $405,270
4,503 Added 0.07%
6,784,068 $558 Million
Q2 2020

Aug 14, 2020

BUY
$46.91 - $78.22 $9.64 Million - $16.1 Million
205,605 Added 3.13%
6,779,565 $530 Million
Q1 2020

May 15, 2020

BUY
$33.8 - $62.9 $7.14 Million - $13.3 Million
211,265 Added 3.32%
6,573,960 $292 Million
Q4 2019

Feb 18, 2020

BUY
$36.08 - $45.83 $198,945 - $252,706
5,514 Added 0.09%
6,362,695 $272 Million
Q3 2019

Nov 14, 2019

BUY
$42.5 - $63.11 $2,337 - $3,471
55 Added 0.0%
6,357,181 $272 Million
Q2 2019

Aug 14, 2019

BUY
$54.93 - $74.36 $93,051 - $125,965
1,694 Added 0.03%
6,357,126 $404 Million
Q1 2019

May 15, 2019

BUY
$39.87 - $69.36 $19.9 Million - $34.6 Million
499,277 Added 8.53%
6,355,432 $441 Million
Q4 2018

Feb 14, 2019

BUY
$38.89 - $77.3 $661 - $1,314
17 Added 0.0%
5,856,155 $255 Million
Q3 2018

Nov 14, 2018

BUY
$71.81 - $90.15 $7.22 Million - $9.07 Million
100,575 Added 1.75%
5,856,138 $447 Million
Q2 2018

Aug 14, 2018

SELL
$48.54 - $85.31 $7.71 Million - $13.6 Million
-158,884 Reduced 2.69%
5,755,563 $442 Million
Q1 2018

May 15, 2018

BUY
$44.33 - $58.52 $41.2 Million - $54.4 Million
929,442 Added 18.64%
5,914,447 $302 Million
Q4 2017

Feb 14, 2018

BUY
$43.54 - $57.32 $39 Million - $51.3 Million
895,266 Added 21.89%
4,985,005 $231 Million
Q3 2017

Nov 14, 2017

BUY
$49.79 - $66.32 $204 Million - $271 Million
4,089,739
4,089,739 $218 Million

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.44B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.